Inactive Instrument
CannPal Animal Therapeutics Limited Stock
Stocks
CP1
AU000000CP17
Biotechnology & Medical Research
| 1 day | +6.25% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 03/06/2016 | |
Baden Bowen
DFI | Director of Finance/CFO | - | 01/10/2016 |
Rayson Tan
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Geoff Starr
CHM | Chairman | - | 07/07/2017 |
Robert Clifford
BRD | Director/Board Member | - | 01/08/2016 |
| Director/Board Member | - | 03/06/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.25% | +13.33% | - | - | 12.26M | |
| -1.15% | -4.19% | +70.02% | +124.86% | 56.71B | |
| -2.45% | -7.83% | +63.92% | +83.15% | 51.3B | |
| +3.27% | +8.91% | +21.21% | +486.76% | 25.26B | |
| -0.81% | -0.42% | -16.24% | -12.47% | 23.65B | |
| +4.21% | +3.68% | +43.55% | -2.16% | 18.69B | |
| -0.05% | +1.01% | +38.02% | -25.91% | 17.71B | |
| +2.34% | +12.50% | +224.02% | +380.99% | 17.7B | |
| -1.08% | +1.41% | +35.56% | - | 14.26B | |
| -1.70% | +3.98% | +28.96% | +190.57% | 14.1B | |
| Average | +0.89% | +4.02% | +56.56% | +153.22% | 26.6B | |
| Weighted average by Cap. | -0.20% | +2.20% | +57.52% | +143.38% |
Employees
-
Choose MarketScreener 
